79083-42-4

Basic information

• Product Name: METHYL-D-ARABINOFURANOSIDE
• Synonyms: METHYL-D-ARABINOFURANOSIDE;D-Arabinofuranoside, Methyl;1-O-methyl-D-arabinofuranoside;(2R,3S,4S)-2-(hydroxymethyl)-5-methoxyoxolane-3,4-diol;(2R,3S,4S)-2-(hydroxymethyl)-5-methoxytetrahydrofuran-3,4-diol
• CAS NO: 79083-42-4
• Molecular Formula: C₆H₁₂O₅
• Molecular Weight: 164.15648
• Mol File: 79083-42-4.mol
• Article Data: 109

Chemical Properties

• Appearance: /
• Density: 1.40
• Storage Temp.: 2-8°C
• CAS DataBase Reference: METHYL-D-ARABINOFURANOSIDE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL-D-ARABINOFURANOSIDE(79083-42-4)
• EPA Substance Registry System: METHYL-D-ARABINOFURANOSIDE(79083-42-4)

Safety Data

• Hazardous Substances Data: 79083-42-4(Hazardous Substances Data)

Usage

General Description

Methyl-D-arabinofuranoside is a chemical compound with the molecular formula C6H12O5. It is a derivative of the sugar arabinose and is commonly used as a substrate in enzymatic assays to study various metabolic pathways, particularly those involving arabinose and its derivatives. Methyl-D-arabinofuranoside is also used in the synthesis of nucleosides and nucleotides, and has potential applications in the pharmaceutical industry for the development of new drugs. In addition, this compound has been studied for its potential as a carbon source for microbial growth, making it of interest in biotechnology and microbiology research. Overall, methyl-D-arabinofuranoside is a versatile compound with diverse applications in biochemistry, pharmaceuticals, and biotechnology.

Upstream product

• 67-56-1 methanol 
• 1114-34-7 D-lyxose 
• 50-69-1 D-ribose 
• 532-20-7 D-Ribose 
• 58-86-6 D-xylose 
• 87-72-9 D-Xylose 
• 609-06-3 L-xylose 
• 5328-37-0 L-arabinose 
• 10323-20-3 D-Arabinose 
• 532-20-7 D-arabinofuranose 
• 6748-95-4 β-D-arabinopyranose 
• 87-72-9 D-lyxose 
• 532-20-7 D-lyxose 
• 87-72-9 L-xylopyranose 

Downstream Products

• 2296-41-5 methyl-tri-O-methyl-arabinofuranoside 
• 50908-04-8 (-)-Methyl-5-O-trityl-β-D-ribofuranosid 
• 67689-93-4 methyl 5-O-trityl-α-D-ribofuranoside 
• 79083-40-2 2,3,5-tri-O-benzyl-1-O-methyl-α-D-xylofuranoside 
• 79083-41-3 2,3,5-tri-O-benzyl-1-O-methyl-β-D-xylofuranoside 
• 13039-66-2 α- and β-methyl 5-O-(p-toluenesulfonyl)xyloside 
• 112245-59-7 methyl 3,5-O-isopropylidene-αβ-D-xylofuranoside 
• 83376-69-6 methyl 2,3-di-O-methyl-D-riboside 
• 83376-70-9 methyl 2,5-di-O-methyl-D-riboside 
• 83376-68-5 methyl 3,5-di-O-methyl-D-riboside 
• 2296-41-5 methyl 2,3,5-tri-O-methyl-D-ribofuranoside 
• 90244-44-3 methyl 2,3,5-tri-O-acetyl-α,β-D-arabinofuranoside 
• 4891-18-3 2,3-anhydro-β-D-ribofuranoside de methyle 
• 4860-82-6 2,3-anhydro-α-D-ribofuranoside de methyle 

Relevant articles and documents

Unexpected furanose/pyranose equilibration of N-glycosyl sulfonamides, sulfamides and sulfamates

De-protected arabino N-glycosyl sulfamides, sulfonamides and sulfamates were found to mutarotate and convert from the furanose to the thermodynamically more stable pyranose form in aqueous solution. The presence of a strongly electron withdrawing group in

Asymmetric Formal Synthesis of (-)-Swainsonine from Chiral-Pool Precursors d -Mannose and d -Arabinose

Carbohydrates have played an important role in organic synthesis. Since they contain many stereocenters, they have been widely used as chiral-pool starting materials. Herein, we report the asymmetric formal synthesis of (-)-swainsonine, which exhibits anticancer and immunosuppressive activities and inhibits lysosomal α-mannosidase activity, from D-mannose and D-arabinose. The synthesis utilized Zn-mediated Bernet-Vasella reaction, Horner-Wadsworth-Emmons olefination, and Grubbs olefin metathesis as key reactions.

MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF

The present disclosure provides oligomeric compounds comprising a modified oligonucleotide having at least one stereo-non-standard nucleoside. An oligomeric compound comprising a modified oligonucleotide consisting of 12-30 linked nucleosides, wherein at least one nucleoside of the modified oligonucleotide is a stereo-non-standard nucleoside; and wherein the oligomeric compound is selected from among an RNAi compound, a modified CRISPR compound, and an artificial mRNA compound.

Preparation method of compound with 3, 4-trans-3, 6-anhydrofuran hexose structure

The invention discloses a preparation method of a compound with a 3, 4-trans-3, 6-dehydrated furan hexose structure and a preparation method of the compound with the 3, 4-trans-3, 6-dehydrated furan hexose structure. The method comprises the following ste